Genomictree (KRX: 228760)
Who is buying Genomictree?
Between Sep 10, 2026 and Oct 13, 2026 (20 trading sessions), foreign investors net bought ₩0.0bn ($0M) of Genomictree, the 551st largest foreign net purchase among 1828 KOSDAQ stocks. Institutions net sold ₩1.5bn ($1M) and retail investors net bought ₩1.3bn ($1M) over the same window. Foreigners were net buyers on 11 of the 20 sessions.
Foreign investors hold 2.88% of Genomictree's listed shares (KRX ownership data as of Oct 13, 2026), up from 2.77% twenty sessions earlier and 1.44% a year ago.
The stock closed at ₩10,280 on Oct 13, 2026: -2.37% over 20 sessions, -62.55% year-to-date, -48.34% over one year. The 52-week range is ₩9,890 – ₩33,300.
View chart data as a table
| Date | Close | Foreign net | Institutions | Retail |
|---|---|---|---|---|
| 2026-10-13 | ₩10,280 | ₩-0.4bn | ₩-0.3bn | +₩0.8bn |
| 2026-10-12 | ₩10,400 | +₩1.3bn | ₩-0.2bn | ₩-1.5bn |
| 2026-10-08 | ₩11,320 | +₩0.2bn | ₩-0.3bn | +₩0.2bn |
| 2026-10-07 | ₩11,940 | +₩0.2bn | ₩-0.4bn | +₩0.2bn |
| 2026-10-06 | ₩12,200 | +₩0.3bn | ₩-0.2bn | ₩-0.1bn |
| 2026-10-02 | ₩12,200 | ₩-0.4bn | ₩-0.0bn | +₩0.4bn |
| 2026-10-01 | ₩12,730 | +₩0.3bn | +₩0.0bn | ₩-0.4bn |
| 2026-09-30 | ₩12,300 | +₩0.1bn | ₩-0.0bn | +₩0.1bn |
| 2026-09-29 | ₩10,950 | ₩-0.2bn | ₩-0.0bn | +₩0.2bn |
| 2026-09-28 | ₩11,330 | +₩0.2bn | +₩0.0bn | ₩-0.3bn |
| 2026-09-23 | ₩11,000 | +₩0.1bn | ₩-0.0bn | +₩0.1bn |
| 2026-09-22 | ₩10,900 | +₩0.1bn | +₩0.0bn | ₩-0.3bn |
| 2026-09-21 | ₩11,270 | ₩-1.4bn | ₩-0.1bn | +₩1.5bn |
| 2026-09-18 | ₩11,960 | ₩-0.0bn | +₩0.1bn | +₩0.2bn |
| 2026-09-17 | ₩10,190 | +₩0.0bn | ₩-0.0bn | +₩0.0bn |
| 2026-09-16 | ₩10,070 | ₩-0.1bn | +₩0.0bn | +₩0.0bn |
| 2026-09-15 | ₩10,130 | +₩0.1bn | +₩0.0bn | ₩-0.1bn |
| 2026-09-14 | ₩10,080 | ₩-0.1bn | +₩0.0bn | +₩0.1bn |
| 2026-09-11 | ₩10,250 | ₩-0.1bn | ₩-0.0bn | +₩0.1bn |
| 2026-09-10 | ₩10,340 | ₩-0.1bn | +₩0.0bn | +₩0.1bn |
| 2026-09-09 | ₩10,530 | ₩-0.0bn | ₩0.0bn | +₩0.0bn |
| 2026-09-08 | ₩10,430 | ₩-0.2bn | ₩0.0bn | +₩0.2bn |
| 2026-09-07 | ₩10,550 | ₩-0.1bn | ₩-0.0bn | +₩0.2bn |
| 2026-09-04 | ₩10,660 | ₩-0.0bn | ₩-0.0bn | +₩0.0bn |
| 2026-09-03 | ₩10,510 | +₩0.1bn | +₩0.0bn | ₩-0.2bn |
| 2026-09-02 | ₩10,630 | +₩1.2bn | +₩0.0bn | ₩-1.6bn |
| 2026-09-01 | ₩11,180 | +₩0.7bn | ₩-0.0bn | ₩-0.7bn |
| 2026-08-31 | ₩11,290 | +₩0.2bn | +₩0.0bn | ₩-0.2bn |
| 2026-08-28 | ₩11,750 | +₩0.1bn | ₩0.0bn | ₩-0.1bn |
| 2026-08-27 | ₩11,760 | ₩-0.1bn | ₩0.0bn | +₩0.1bn |
| 2026-08-26 | ₩12,000 | +₩0.2bn | ₩-0.0bn | ₩-0.2bn |
| 2026-08-25 | ₩11,850 | ₩-0.1bn | +₩0.0bn | +₩0.1bn |
| 2026-08-24 | ₩12,230 | +₩0.1bn | +₩0.0bn | ₩-0.1bn |
| 2026-08-21 | ₩12,080 | ₩-0.2bn | ₩-0.0bn | +₩0.0bn |
| 2026-08-20 | ₩12,460 | +₩0.0bn | ₩-0.0bn | ₩-0.0bn |
| 2026-08-19 | ₩11,800 | ₩-0.4bn | ₩-0.0bn | +₩0.5bn |
| 2026-08-18 | ₩12,070 | ₩-0.2bn | +₩0.0bn | +₩0.2bn |
| 2026-08-14 | ₩13,300 | ₩-0.1bn | +₩0.0bn | +₩0.1bn |
| 2026-08-13 | ₩13,400 | ₩-0.5bn | +₩0.0bn | +₩0.5bn |
| 2026-08-12 | ₩13,870 | ₩-1.0bn | +₩0.0bn | +₩1.0bn |
| 2026-08-11 | ₩14,860 | ₩-1.5bn | ₩-0.1bn | +₩1.8bn |
| 2026-08-10 | ₩13,430 | +₩0.2bn | ₩-0.0bn | ₩-0.2bn |
| 2026-08-07 | ₩12,700 | ₩-0.0bn | ₩-0.0bn | +₩0.0bn |
| 2026-08-06 | ₩13,020 | ₩-0.1bn | ₩0.0bn | +₩0.1bn |
| 2026-08-05 | ₩13,190 | ₩-0.1bn | ₩-0.0bn | +₩0.1bn |
| 2026-08-04 | ₩12,780 | +₩0.7bn | +₩0.0bn | ₩-0.7bn |
| 2026-08-03 | ₩11,730 | +₩0.4bn | +₩0.0bn | ₩-0.4bn |
| 2026-07-31 | ₩11,340 | ₩-0.0bn | ₩-0.0bn | ₩-0.0bn |
| 2026-07-30 | ₩10,330 | +₩0.2bn | +₩0.0bn | ₩-0.2bn |
| 2026-07-29 | ₩10,460 | ₩-0.0bn | +₩0.0bn | +₩0.1bn |
| 2026-07-28 | ₩11,250 | ₩-0.2bn | +₩0.0bn | +₩0.2bn |
| 2026-07-27 | ₩12,150 | ₩-0.1bn | +₩0.0bn | +₩0.1bn |
| 2026-07-24 | ₩11,870 | +₩0.0bn | ₩0.0bn | ₩-0.0bn |
| 2026-07-23 | ₩12,290 | +₩0.7bn | ₩0.0bn | ₩-0.7bn |
| 2026-07-22 | ₩11,350 | ₩-0.2bn | ₩0.0bn | +₩0.1bn |
| 2026-07-21 | ₩11,790 | ₩-0.6bn | +₩0.0bn | ₩-0.1bn |
| 2026-07-20 | ₩11,960 | ₩-0.8bn | ₩-0.0bn | +₩0.8bn |
| 2026-07-16 | ₩11,810 | ₩-0.2bn | +₩0.0bn | +₩0.1bn |
| 2026-07-15 | ₩12,200 | ₩-0.2bn | ₩-0.0bn | ₩-0.2bn |
| 2026-07-14 | ₩12,030 | ₩-1.1bn | ₩-0.0bn | +₩0.7bn |
| 2026-07-13 | ₩11,000 | ₩-0.2bn | ₩-0.0bn | +₩0.2bn |
Investor flows summary
| Window | Foreign | (USD) | Institutions | Retail |
|---|---|---|---|---|
| 1 day | ₩-0.4bn | $-0M | ₩-0.3bn | +₩0.8bn |
| 5 days | +₩1.5bn | +$1M | ₩-1.5bn | ₩-0.4bn |
| 20 days | +₩0.0bn | +$0M | ₩-1.5bn | +₩1.3bn |
Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.
Frequently asked questions
Are foreign investors buying Genomictree stock?
Over the last 5 sessions foreign investors net bought ₩1.5bn ($1M) of Genomictree; over 60 sessions they net sold ₩3.6bn ($3M); since Jan 1, 2026 they net bought ₩4.2bn ($3M). Over 20 sessions the stock is the 551st largest foreign net purchase among 1828 KOSDAQ stocks.
How much of Genomictree do foreign investors own?
Foreign investors own 2.88% of Genomictree's shares as of Oct 13, 2026, versus 1.44% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.
Who is on the other side — institutions or retail investors?
Over 20 sessions institutions net sold ₩1.5bn ($1M) and retail investors net bought ₩1.3bn ($1M) of Genomictree. Foreign buying is being met mainly by institutional selling.
Is Genomictree listed on KOSPI or KOSDAQ?
Genomictree (지노믹트리) trades on KOSDAQ under KRX code 228760 in the Biotech & Pharma group, with a market capitalization of ₩0T ($0.2B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.
Annual financials
| Fiscal year | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| 2023 | ₩3bn ($3M) | – | -₩17bn (-$13M) | -₩9bn (-$7M) |
| 2024 | ₩2bn ($2M) | -30.90% | -₩15bn (-$11M) | -₩10bn (-$8M) |
| 2025 | ₩4bn ($3M) | +59.20% | -₩11bn (-$8M) | -₩9bn (-$7M) |
Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1333.09/$) for reference only.